HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 01/22/2013 -- Bank of America (NYSE:BAC) Chief Brian Moynihan's Project New BAC has been a model of cost reduction since its unveiling in the fall of 2011, when he announced planned cuts of $5 billion by the end of this year. By Nov. 2012, Moynihan noted that the bank had sold off $60 billion in non-core assets, allowing it to pad capital reserves by $12 billion. Recently, B of A has done even more trimming, selling off more big blocks of mortgage-servicing rights. The effects of this strategy showed up nicely in the bank's recent fourth-quarter report, at least as far as capital reserves are concerned. B of A now sports a Basel III Tier 1 common capital ratio of 9.25%, up from 8.97% in the third quarter.
Should Investor Book Profit and Exit From BAC: Need Instant Reply Check Here
General Electric (NYSE:GE) , which soared nearly 3.5% after a positive earnings report. The company reported higher profits from all of its business segments, with overall earnings jumping 8% on a 4% gain in revenue. Record backlogs point to further gains ahead. With double-digit percentage gains in its oil and gas and energy management divisions, the strategic direction that GE chose in returning to its industrial roots, while also developing new niche specialties, has paid off, and could continue to do so well into the future.
Is GE Going To Move Higher As Many Investors Expect: Find Out Here
Nokia (NYSE:NOK) is expected to report Q4 earnings on Jan. 24. Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Nokia's revenues will wither -18.2% and EPS will drop -37.5%. The average estimate for revenue is $10.63 billion. On the bottom line, the average EPS estimate is $0.05. Last quarter, Nokia booked revenue of $9.30 billion. GAAP reported sales were 23% lower than the prior-year quarter's $12.08 billion. Last quarter, non-GAAP EPS came in at -$0.09. GAAP EPS were -$0.34 for Q3 compared to -$0.03 per share for the prior-year quarter.For the preceding quarter, gross margin was 27.6%, 50 basis points worse than the prior-year quarter. Operating margin was -1.1%, 160 basis points worse than the prior-year quarter. Net margin was -13.4%, 1,260 basis points worse than the prior-year quarter.
Is NOK will continue moving higher? Find out where NOK is headed next with a FREE TREND ANALYSIS REPORT
Pfizer (NYSE:PFE) is scheduled to report Q4 '12 earnings on January 29th, 2013, before the market opens. Pfizer rose 16% in calendar 2012, excluding the dividend. Q4 '12 Street consensus is looking at $0.44 in EPS on $14.4 billion in revenues for declines of 12% and 16% ,respectively. Lipitor coming off patent in 2012 obviously impacted the results, but Q3 '12 revenues were even lighter than expected given Lipitor. 2013 consensus is expected at $2.29 and $57.65 billion for expected year-over-year growth of 6% on a 1% expected decline of revenues. With the Zoetis (PFE's animal health unit) spin-off scheduled for early 2013, proceeds are expected to go towards share repurchases. Pfizer has an 8% "free-cash-flow yield" and has plenty of cash to put into the dividend and share buyback, but the question remains, how much of this already is modeled into the share price.
Should Investor Book Profit Or Hold PFE This Range: Check Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to loose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)